Publication:
Development of a Scalable Pharmacogenomic Clinical Decision Support Service

Thumbnail Image

Date

2013

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

American Medical Informatics Association
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Fusaro, Vincent A., Catherine Brownstein, Wendy Wolf, Catherine Clinton, Sarah Savage, Kenneth D. Mandl, David Margulies, and Shannon Manzi. 2013. “Development of a Scalable Pharmacogenomic Clinical Decision Support Service.” AMIA Summits on Translational Science Proceedings 2013 (1): 60.

Research Data

Abstract

Advances in sequencing technology are making genomic data more accessible within the healthcare environment. Published pharmacogenetic guidelines attempt to provide a clinical context for specific genomic variants; however, the actual implementation to convert genomic data into a clinical report integrated within an electronic medical record system is a major challenge for any hospital. We created a two-part solution that integrates with the medical record system and converts genetic variant results into an interpreted clinical report based on published guidelines. We successfully developed a scalable infrastructure to support TPMT genetic testing and are currently testing approximately two individuals per week in our production version. We plan to release an online variant to clinical interpretation reporting system in order to facilitate translation of pharmacogenetic information into clinical practice.

Description

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories